OVERVIEW

Neurology: Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study is organized by American Academy of Neurology (AAN).

Released: 1/23/2018
Expires: 1/23/2021

Accreditation:
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:
Upon completion of the article by Hernandez-Diaz et al, the participant should be able to:
• State differences between women taking topiramate and women unexposed to topiramate in this study
• Discuss the relative risk of oral clefts in infants exposed to topiramate in this study compared to infants who were unexposed or exposed to lamotrigine
• Discuss factors which increased the risk of oral clefts in infants exposed to topiramate

Credits
  • 0.75 CME
  • SPECIALITIES

    NeurologyMidwifery

    RELATED ONLINE COURSES